VAERS reports by lot

Merck Pneumococcal lot S021740: VAERS reports

65 VAERS reports list lot S021740 as a Merck Pneumococcal vaccine, received between 2019-09-17 and 2021-01-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
8%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction8949%
Dermatological (non-injection-site)1810%
Allergic / Anaphylactic179%
Musculoskeletal169%
General / Systemic (non-local)169%
Cardiac / Cardiovascular116%
Neurological74%
Respiratory53%
Gastrointestinal42%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida7
New York5
Pennsylvania5
Texas4
Colorado3
Virginia3
California3
Nevada2
Illinois2
Massachusetts2
Iowa2
Oregon2

Reports by month received

2019-097
2019-1023
2019-1113
2019-126
2020-012
2020-021
2020-034
2020-075
2020-093
2021-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.